Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-25 @ 12:33 PM
NCT ID:
NCT03269695
Pre Assignment Details:
Participants with active histologic Ulcerative Colitis (as defined by a total Mayo Score \>= 4 but \<=9 and an endoscopic subscore \>=2) for \>=4 months, and on a stable dose 5 to 10 mg/kg of Remicade, or protocol specified infliximab biosimilars for a minimum of 14 weeks prior to study entry with no anticipation of need for change in infliximab treatment regimen throughout the study were enrolled.
Recruitment Details:
A total of 46 participants were screened , of whom 20 were randomized and treated (10 participants each in the Placebo + Infliximab and PF-06687234 20 mg + Infliximab treatment groups). Fifteen participants completed the treatment.
Study:
NCT03269695
Study Brief:
Results Section:
NCT03269695